Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-014768
Filing Date
2005-03-10
Accepted
2005-03-10 10:39:25
Documents
1
Period of Report
2005-03-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4560
  Complete submission text file 0001209191-05-014768.txt   6540
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747
Business Address 631-962-2000
LUNDEMOSE ANKER MD, PH.D, DSC (Reporting) CIK: 0001314821 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15190 | Film No.: 05671030